Autism Spectrum Disorder in Adolescence

When the Diagnosis Has Been Missed

Autism spectrum disorder (ASD) in adolescence is frequently recognized late. This is particularly true for young people without intellectual disability and for girls, who often carry years of anxiety, depression, or behavioral diagnoses while the underlying developmental picture goes unexamined. By the time a family arrives at a psychiatric evaluation, the clinical presentation is often layered with secondary conditions that have accumulated in the absence of an accurate diagnosis and appropriate support structures.

According to the CDC's Autism and Developmental Disabilities Monitoring (ADDM) Network, approximately 1 in 31 children aged 8 years in the United States meets criteria for ASD. Children without co-occurring intellectual disability receive their diagnoses significantly later than those with intellectual disability, with median ages of first diagnosis often extending well into the school years. For adolescents, particularly girls, the gap between symptom onset and formal diagnosis can span a decade or more.

The Phenomenon of Camouflaging

A growing body of research has identified "camouflaging" or "masking" as a central mechanism underlying late diagnosis, particularly in females. Camouflaging refers to the conscious or unconscious suppression of autistic traits to appear neurotypical, and encompasses strategies such as mimicking observed social behaviors, forcing eye contact, and scripting conversational responses. While these strategies may facilitate short-term social navigation, longitudinal research demonstrates that sustained camouflaging is strongly associated with exhaustion, burnout, and elevated rates of anxiety and depression. It is precisely this adaptive capacity that renders the underlying developmental disorder invisible to clinicians who are not specifically looking for it.

By adolescence, undiagnosed ASD often presents not merely as social communication differences, but as school refusal, severe anxiety, chronic sleep disruption, profound behavioral dysregulation, or a persistent sense of social alienation that resists conventional psychiatric treatment. Arzilence Psychiatry exists to examine that picture properly.

Who We Evaluate

Our autism spectrum disorder clinical evaluation and care service is led by our Director of Child and Adolescent Psychiatry, Dr. Jared L. Reichenberg, with extensive experience delivering autism spectrum disorder care across the full spectrum of acuity. We serve adolescents ages 13 and older and young adults.

Why Clinical Precision Matters

Clinical precision in adolescence is consequential. An accurate formulation changes the trajectory of care, informs school accommodations and support structures, and gives the adolescent and family a coherent framework for understanding longstanding patterns of behavior, emotion, and social experience. Misdiagnosis or delayed diagnosis prolongs suffering and often leads to treatments that address secondary symptoms while leaving the primary developmental picture unaddressed.

Arzilence operates on an integrated model: psychotherapy and medication management are delivered together by the same psychiatrist, within the same treatment relationship. There are no brief medication checks. Initial evaluations are typically 60 to 90 minutes and often extend across more than one session when the clinical picture warrants it. Education is treated as a clinical intervention, not a marketing supplement.